Phase XII, group 2 - 01.07.2015 - 30.06.2018

GR 2526

Exploiting the immuno­peptidome of experimental glioma

Israeli Partner: A. Admon, Technion
German Partner: M. Platten, DKFZ

Ca.-No 165

Understanding the func­tional impact of genetic alterations in brain tumors

Israeli Partner: D. Friedmann-Morvinski, Tel Aviv University
German Partner: J. Gronych, D. Jones, DKFZ

Publications

No publications available.

Ca.-No 166

Functional characterization of pathogenic changes in the microenvironment of chronic lymphocytic leu­kemia, with a focus on immunomodulatory SLAM receptors

Israeli Partner: I. Shachar, Weizmann Institute
German Partner: M. Seiffert, DKFZ

Ca.-No 167

A comprehensive func­tional analysis of niche-stem cell interactions

Israeli Partner: L. Gilboa, Weizmann Institute
German Partner: M. Boutros, DKFZ

Publications

No publications available.

Ca.-No 168

Regulation of normal and leukemic human stem cells by the endothelial blood-bone marrow barrier

Israeli Partner: T. Lapidot, Weizmann Institue
German Partner: H. Augustin, DKFZ

Ca.-No 169

A novel mode of non-coding RNA in gene regulation: An E2F1-dependent antisense RNA activates expression of the proto-oncogene SPHK

Israeli Partner: D. Ginsberg, Bar-Ilan University
German Partner: I. Grummt, DKFZ

Form

Form data is loaded ...